Journal articles on the topic 'GMDP'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'GMDP.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Antsiferova, Yuliya, Nataliya Sotnikova, and Elena Parfenyuk. "Different Effects of the Immunomodulatory Drug GMDP Immobilized onto Aminopropyl Modified and Unmodified Mesoporous Silica Nanoparticles upon Peritoneal Macrophages of Women with Endometriosis." BioMed Research International 2013 (2013): 1–10. http://dx.doi.org/10.1155/2013/924362.
Full textKuznetsova, E. G., O. M. Kuryleva, L. A. Salomatina, S. V. Kursakov, S. V. Guryanova, and V. I. Sevastyanov. "Influence of microemulsion components on transdermal delivery of immunomodulator glucosaminylmuramyl dipeptide." Russian Journal of Transplantology and Artificial Organs 22, no. 3 (2020): 149–55. http://dx.doi.org/10.15825/1995-1191-2020-3-149-155.
Full textMakatsariya, A. D., V. O. Bitsadze, J. Kh Khizroeva, G. Kh Vikulov, M. A. Gomberg, and A. A. Khryanin. "Efficacy and safety of glucosaminylmuramyl dipeptide in treatment of human papillomavirus-associated diseases: a systematic review." Obstetrics, Gynecology and Reproduction 13, no. 2 (2019): 132–54. http://dx.doi.org/10.17749/2313-7347.2019.13.2.132-154.
Full textGuryanova, Svetlana V., Olga B. Gigani, Georgii O. Gudima, Anastasiya M. Kataeva, and Natalya V. Kolesnikova. "Dual Effect of Low-Molecular-Weight Bioregulators of Bacterial Origin in Experimental Model of Asthma." Life 12, no. 2 (2022): 192. http://dx.doi.org/10.3390/life12020192.
Full textProdeus, A. P., G. N. Gildeeva, D. R. Mamilyaeva, and I. G. Kozlov. "GLUCOSAMINYLMURAMYLDIPEPTIDE: REVIEW OF USE AND EFFECTIVENESS EVALUATION IN PEDIATRIC PRACTICE." Pediatria. Journal named after G.N. Speransky 100, no. 2 (2021): 157–66. http://dx.doi.org/10.24110/0031-403x-2021-100-2-157-166.
Full textLaman, Alexander G., Richard Lathe, Anna O. Shepelyakovskaya, et al. "Muramyl peptides activate innate immunity conjointly via YB1 and NOD2." Innate Immunity 22, no. 8 (2016): 666–73. http://dx.doi.org/10.1177/1753425916668982.
Full textGudyrev, Oleg, Tatyana Andronova, and Evgeniya Nesterova. "The results of the study of the carcinogenic properties of glucosaminylmuramyldipeptide GMDP in chronic experiments in mice and rats." Research Results in Pharmacology 4, no. 4 (2018): 97–106. http://dx.doi.org/10.3897/rrpharmacology.4.32191.
Full textGudyrev, Oleg S., Tatyana M. Andronova, and Evgeniya I. Nesterova. "The results of the study of the carcinogenic properties of glucosaminylmuramyldipeptide GMDP in chronic experiments in mice and rats." Research Results in Pharmacology 4, no. (4) (2018): 97–106. https://doi.org/10.3897/rrpharmacology.4.32191.
Full textNemtsova, E. R., O. A. Bezborodova, N. B. Morozova, et al. "Efficacy of combined treatment of experimental tumors with cytostatic agents and GMDP-A." Russian Journal of Biotherapy 16, no. 2 (2017): 13–22. http://dx.doi.org/10.17650/1726-9784-2017-16-2-13-22.
Full textGuryanova, Svetlana V., and Anastasiya Kataeva. "Inflammation Regulation by Bacterial Molecular Patterns." Biomedicines 11, no. 1 (2023): 183. http://dx.doi.org/10.3390/biomedicines11010183.
Full textBhushan, Monica, Kathleen McElhone, and Christopher EM Griffiths. "GMDP and psoriasis." Lancet 352, no. 9143 (1998): 1857. http://dx.doi.org/10.1016/s0140-6736(05)79923-2.
Full textWilliamson, D., M. Chawla, and R. Marks. "GMDP for psoriasis." Lancet 352, no. 9127 (1998): 545. http://dx.doi.org/10.1016/s0140-6736(05)79253-9.
Full textNesterova, I. V., V. V. Malinovskaya, S. V. Khaydukov, D. L. Nguyen Thi, G. A. Chudilova, and L. V. Lomtatidze. "DIFFERENTIATED EFFECTS OF GLUCOSAMINYLMURAMILDIPEPTIDE ON THE NONTRANSFORMED AND EXPERIMENTALLY TRANSFORMED PHENOTYPE OF CD62L+CD63+CD66d+ NEUTROPHILIC GRANULOCYTES IN CONVENTIONALLY HEALTHY PEOPLE." Medical Immunology (Russia) 20, no. 6 (2018): 847–54. http://dx.doi.org/10.15789/1563-0625-2018-6-847-854.
Full textGuryanova, Svetlana V., Artem S. Ferberg, and Ilya A. Sigmatulin. "Inflammatory response modulation by epinephrine and norepinephrine." RUDN Journal of Medicine 27, no. 3 (2023): 329–41. http://dx.doi.org/10.22363/2313-0245-2023-27-3-329-341.
Full textAlekseeva, L. G., A. G. Laman, E. A. Meshcherykova, A. O. Shepelyakovskaya, F. A. Brovko, and V. T. Ivanov. "Extracellular Cold Shock Protein YB-1 Induces Tolerance to GMDP and LPS in Mouse Macrophage Cell Line J774." Биоорганическая химия 49, no. 4 (2023): 384–91. http://dx.doi.org/10.31857/s013234232303003x.
Full textGuryanova, Svetlana V., Natalia A. Kudryashova, Anastasiya A. Kataeva, Bubusaira T. Orozbekova, Natalia V. Kolesnikova, and Alexandr G. Chuchalin. "Novel approaches to increase resistance to acute respiratory infections." RUDN Journal of Medicine 25, no. 3 (2021): 181–95. http://dx.doi.org/10.22363/2313-0245-2021-25-3-181-195.
Full textKonorev, M. R., E. N. Tyshevich, and R. A. Pavlyukov. "Application of N-Acetyl-Glucosaminil-N-Acetyl-Muramyl Dipeptide during Triple Component Anti-Helicobacter Pylori Therapy in the Period of Coronavirus Infection COVID-19." Russian Journal of Gastroenterology, Hepatology, Coloproctology 33, no. 2 (2023): 60–69. http://dx.doi.org/10.22416/1382-4376-2023-33-2-60-69.
Full textNesterova, I. V., G. A. Chudilova, and Yu V. Teterin. "Ambivalent <i>in vitro</i> effect of immunoregulatory peptides on antigen-presenting subsets of neutrophil granulocytes in purulent inflammatory diseases." Russian Journal of Immunology 28, no. 2 (2025): 287–94. https://doi.org/10.46235/1028-7221-17026-aiv.
Full textFilippenko, A. V., I. A. Ivanova, N. D. Omelchenko, and A. A. Trufanova. "Adjuvant activity of glucosaminylmuramyldipeptide and prospects of its use for the treatment and prevention of infectious diseases." Medical Herald of the South of Russia 15, no. 4 (2024): 72–78. https://doi.org/10.21886/2219-8075-2024-15-4-72-78.
Full textRoh, Tae Hoon, Young Hwa Kim, So Hyun Park, et al. "TMIC-14. DIFFUSE P16INK4A EXPRESSION IS ASSOCIATED WITH TUMOR CELL SENESCENCE AND SENESCENCE-ASSOCIATED SECRETARY PHENOTYPE RELATED TO IMMUNE MICROENVIRONMENT IN GLIOBLASTOMAS." Neuro-Oncology 24, Supplement_7 (2022): vii274. http://dx.doi.org/10.1093/neuonc/noac209.1058.
Full textKim, S., T. Roh, T. Park, and J. Kim. "P12.01.A TUMOR CELL SENESCENCE AND IMMUNE MICROENVIRONMENT IN GLIOBLASTOMAS." Neuro-Oncology 25, Supplement_2 (2023): ii96. http://dx.doi.org/10.1093/neuonc/noad137.320.
Full textMacPherson, Sandra. "GMDP - a promising orally active immunomodulator." Inpharma Weekly &NA;, no. 1021 (1996): 3–4. http://dx.doi.org/10.2165/00128413-199610210-00003.
Full textWu, Jie, Haixiang Zhang, Jie Feng, et al. "MDPN: Multilevel Distribution Propagation Network for Few-Shot Image Classification." Applied Sciences 13, no. 11 (2023): 6518. http://dx.doi.org/10.3390/app13116518.
Full textTURÁNEK, J., A. KAšNÁ, B. KOUDELA, M. LEDVINA, and A. D. MILLER. "Stimulation of innate immunity in newborn kids againstCryptosporidium parvuminfection-challenge by intranasal/per-oral administration of liposomal formulation of N-L18-norAbu-GMDP adjuvant." Parasitology 131, no. 5 (2005): 601–8. http://dx.doi.org/10.1017/s0031182005007924.
Full textХоперская, О. В., Е. В. Енькова, Л. К. Джиджихия та Д. А. Чимшит. "Эффективность и безопасность применения глюкозаминилмурамилдинептида в терапии папилломавирусной инфекции". Issues of practical colposcopy. Genital infections, № 1 (4 квітня 2025): 13–24. https://doi.org/10.46393/27826392_2025_1_13-24.
Full textGolovina, T. N., L. V. Samochvalova, I. S. Litvinov, G. Fattachova, and V. A. Nesmeyanov. "Biochemical characterization of GMDP binding sites on murine macrophages." Immunology Letters 56 (May 1997): 68. http://dx.doi.org/10.1016/s0165-2478(97)85259-5.
Full textGolovina, T. "Biochemical characterization of GMDP binding sites on murine macrophages." Immunology Letters 56, no. 1-3 (1997): 68. http://dx.doi.org/10.1016/s0165-2478(97)87097-6.
Full textKalyuzhin, Oleg V., Tatiana M. Andronova, and Alexander V. Karaulov. "BCG, muramylpeptides, trained immunity (part II): a low molecular weight alternative to multicomponent bacterial immunostimulants for prevention of respiratory infections during a pandemic." Terapevticheskii arkhiv 93, no. 1 (2021): 108–13. http://dx.doi.org/10.26442/00403660.2021.01.200554.
Full textFernandes Júnior, Francisco, Edson Luis de Azambuja Ribeiro, Amanda de Freitas Pena, Fernando Augusto Grandis, Lais Neri Vidotto, and Thaís Campos de Freitas. "Parâmetros Produtivos de Cordeiros Santa Inês e Dorper Abatidos com Diferentes Espessuras de Gordura Subcutânea." Ensaios e Ciência C Biológicas Agrárias e da Saúde 27, no. 1 (2023): 70–78. http://dx.doi.org/10.17921/1415-6938.2023v27n1p70-78.
Full textPetrova, Elena E., Maria A. Simonova, Ravilya L. Komaleva та ін. "GMDP augments antitumor action of the CP/TNFα combination in vivo". Biomedicine & Pharmacotherapy 64, № 4 (2010): 240–48. http://dx.doi.org/10.1016/j.biopha.2009.06.019.
Full textMeshcheryakova, Elena A., Konstantin S. Mineev, Pavel E. Volynski, Tatiana M. Andronova та Vadim T. Ivanov. "GMDP: unusual physico-chemical and biological properties of the anomeriс forms". Journal of Peptide Science 21, № 9 (2015): 717–22. http://dx.doi.org/10.1002/psc.2796.
Full textKOLESNIKOVA, N. V. "CLINICAL AND IMMUNOLOGICAL EFFICACY OF MURAMYLDIPEPTIDE (GMDP) IN FERTILITY DISORDERS (scientific review)." Kubanskij nauchnyj medicinskij vestnik, no. 5 (January 1, 2017): 120–28. http://dx.doi.org/10.25207/1608-6228-2017-24-5-120-128.
Full textNesterova, I. V., G. A. Chudilova, V. N. Pavlenko, S. V. Kovaleva, V. A. Tarakanov, and N. K. Barova. "Effects of NOD1 and NOD2 agonists polymuramyl as well as NOD2 agonist glucosaminylmuramyldipeptide on phenotype of neutrophile granulocyte CD64-CD16+CD32+CD11b+, CD16+CD62L+CD63-, CD16+CD62L+CD63+ subsets." Russian Journal of Immunology 23, no. 4 (2020): 411–18. http://dx.doi.org/10.46235/1028-7221-455-eon.
Full textKhalturina, Evgeniya O., N. V. Garskova, and A. D. Shemetova. "Personalized approach to immune system rehabilitation in patients with year-round allergic rhinitis suffering from recurrent ARVI and recurrent herpes virus infections." Russian Journal of Infection and Immunity 14, no. 3 (2024): 623–31. http://dx.doi.org/10.15789/2220-7619-pat-16826.
Full textGuryanova, Svetlana V., Ilya A. Sigmatulin, Olga O. Gigani, and Sofia A. Lipkina. "Mechanisms of Regulation Allergic and Autoimmune Reactions by Bacterial Origin Bioregulators." RUDN Journal of Medicine 27, no. 4 (2023): 470–82. http://dx.doi.org/10.22363/2313-0245-2023-27-4-470-482.
Full textGuryanova, S. V., and R. M. Khaitov. "Glucosaminylmuramyldipeptide - GMDP: effect on mucosal immunity (on the issue of immunotherapy and immunoprophylaxis)." Immunologiya 41, no. 2 (2020): 174–83. http://dx.doi.org/10.33029/0206-4952-2020-41-2-174-183.
Full textGuryanova, S. V., A. M. Gaponov, V. M. Pisarev, et al. "Glucosaminylmuramyl dipeptide acid (GMDP-A) modulates intracellular signaling pathways in natural killer cells." Immunologiya 41, no. 3 (2020): 235–48. http://dx.doi.org/10.33029/0206-4952-2020-41-3-235-248.
Full textLinzner, Dominik, and Heinz Koeppl. "A Variational Perturbative Approach to Planning in Graph-Based Markov Decision Processes." Proceedings of the AAAI Conference on Artificial Intelligence 34, no. 05 (2020): 7203–10. http://dx.doi.org/10.1609/aaai.v34i05.6210.
Full textZhao, Xiaoqing, Kun Tan, Pengfei Xie, Bing Chen, and Junwei Pu. "Multiobjective Land-Use Optimization Allocation in Eucalyptus-Introduced Regions Based on the GMDP–ACO Model." Journal of Urban Planning and Development 147, no. 2 (2021): 05021004. http://dx.doi.org/10.1061/(asce)up.1943-5444.0000664.
Full textTITOV, VLADIMIR M., ELENA A. MESHCHERYAKOVA, TAMARA A. BALASHOVA, TATYANA M. ANDRONOVA, and VADIM T. IVANOV. "Synthesis and immunological evaluation of the conjugates composed from a muramyl peptide GMDP and tuftsin." International Journal of Peptide and Protein Research 45, no. 4 (2009): 348–55. http://dx.doi.org/10.1111/j.1399-3011.1995.tb01048.x.
Full textGuryanova, S., Roman Khanferyan, T. Andronova, and Lawrence M. Dubuske. "Impact of the NOD2 ligand GMDP on IgE and Cytokine Production in Allergy and Immune Deficiency." Journal of Allergy and Clinical Immunology 143, no. 2 (2019): AB109. http://dx.doi.org/10.1016/j.jaci.2018.12.332.
Full textLi, C. G., S. Kumar, P. W. Ledger, J. M. Ponting, M. Carette, and E. Allan. "Glucosaminylmuramyl dipeptide (GMDP) modulates endothelial cell activities in vitro but has no effect on angiogenesis in vivo." Inflammation Research 46, no. 9 (1997): 348–53. http://dx.doi.org/10.1007/s000110050200.
Full textAlekseeva, L. G., A. G. Laman, E. A. Meshcherykova, A. O. Shepelyakovskaya, F. A. Brovko, and V. T. Ivanov. "Extracellular Cold Shock Protein YB-1 Induces Tolerance to GMDP and LPS in Mouse Macrophage Cell Line J774." Russian Journal of Bioorganic Chemistry 49, no. 4 (2023): 751–57. http://dx.doi.org/10.1134/s1068162023030032.
Full textKnotigová, Pavlína Turánek, Daniel Zyka, Josef Mašek, et al. "Molecular Adjuvants Based on Nonpyrogenic Lipophilic Derivatives of norAbuMDP/GMDP Formulated in Nanoliposomes: Stimulation of Innate and Adaptive Immunity." Pharmaceutical Research 32, no. 4 (2015): 1186–99. http://dx.doi.org/10.1007/s11095-014-1516-y.
Full textAdeleye, T. A., C. Moreno, J. Ivanyi та R. Aston. "The modulation of tumour necrosis factor-α, interleukin-1α and glucose levels with GMDP and other analogues of muramyl dipeptide". APMIS 102, № 1-6 (1994): 145–52. http://dx.doi.org/10.1111/j.1699-0463.1994.tb04859.x.
Full textNguyen, Yen T. M., Manabu Fujisawa, Tran B. Nguyen, et al. "S100a8/S100a9-Emmprin-Vegfa Axis Initiated By Tet2-Deficient Immune Cells Exacerbates Lung Cancer Progression through Promotion of Angiogenesis." Blood 138, Supplement 1 (2021): 3276. http://dx.doi.org/10.1182/blood-2021-151723.
Full textKhmel’nitskij, Roman A., and Аndrej V. Vislobokov. "Clinical feasibility study of an immunotropic drug for treatment of complicated pyodermas." Research Results in Pharmacology 6, no. 3 (2020): 51–57. http://dx.doi.org/10.3897/rrpharmacology.6.50797.
Full textKhmel'nitskij, Roman A., and Andrej V. Vislobokov. "Clinical feasibility study of an immunotropic drug for treatment of complicated pyodermas." Research Results in Pharmacology 6, no. (3) (2020): 51–57. https://doi.org/10.3897/rrpharmacology.6.50797.
Full textLyons, K. "Factors limiting the oral bioavailability of N-acetylglucosaminyl-N-acetylmuramyl dipeptide (GMDP) and enhancement of absorption in rats by delivery in a water-in-oil microemulsion." International Journal of Pharmaceutics 199, no. 1 (2000): 17–28. http://dx.doi.org/10.1016/s0378-5173(00)00349-5.
Full textLaman, A. G., A. O. Shepelyakovskaya, Kh M. Boziev, G. V. Savinov, F. A. Brovko, and V. A. Nesmeyanov. "A method for the preparation of adjuvant peptide mimetics of GMDP with the use of monoclonal antibodies and combinatorial libraries of peptides in the format of phage display." Russian Journal of Bioorganic Chemistry 36, no. 2 (2010): 157–63. http://dx.doi.org/10.1134/s1068162010020032.
Full text